| Authors: |
Roca CP; VIB Center for Brain and Disease Research, Leuven, Belgium. carlosproca@gmail.com.; Department of Microbiology and Immunology, KU Leuven - University of Leuven, Leuven, Belgium. carlosproca@gmail.com.; Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Cambridge, UK. carlosproca@gmail.com., Burton OT; Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Cambridge, UK., Gergelits V; Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Cambridge, UK., Prezzemolo T; VIB Center for Brain and Disease Research, Leuven, Belgium.; Department of Microbiology and Immunology, KU Leuven - University of Leuven, Leuven, Belgium., Whyte CE; Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Cambridge, UK., Halpert R; BD Life Sciences-FlowJo, Ashland, OR, USA., Kreft Ł; VIB Bioinformatics Core, Ghent, Belgium., Collier J; VIB Bioinformatics Core, Ghent, Belgium., Botzki A; VIB Bioinformatics Core, Ghent, Belgium., Spidlen J; BD Life Sciences-FlowJo, Ashland, OR, USA., Humblet-Baron S; VIB Center for Brain and Disease Research, Leuven, Belgium.; Department of Microbiology and Immunology, KU Leuven - University of Leuven, Leuven, Belgium., Liston A; VIB Center for Brain and Disease Research, Leuven, Belgium. adrian.liston@babraham.ac.uk.; Department of Microbiology and Immunology, KU Leuven - University of Leuven, Leuven, Belgium. adrian.liston@babraham.ac.uk.; Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Cambridge, UK. adrian.liston@babraham.ac.uk. |
